[{"address1": "2400 Skymark Avenue", "address2": "Unit 6", "city": "Mississauga", "state": "ON", "zip": "L4W 5K5", "country": "Canada", "phone": "647 476 1350", "fax": "647 847 3739", "website": "https://www.profoundmedical.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.", "fullTimeEmployees": 131, "companyOfficers": [{"maxAge": 1, "name": "Dr. Arun Swarup Menawat MBA, Ph.D.", "age": 68, "title": "Chairman of the Board & CEO", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 435869, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rashed  Dewan", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 215177, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mathieu  Burtnyk", "age": 41, "title": "Chief Operating Officer", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 215177, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hartmut  Warnken", "age": 50, "title": "Senior Vice President for Strategic Alliances", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 226167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Abbey  Goodman", "age": 40, "title": "Chief Commercial Officer of Global", "yearBorn": 1983, "fiscalYear": 2023, "totalPay": 374346, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Kilmer", "title": "Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jacques F. Cornet", "age": 67, "title": "VP of International Sales & Marketing", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Sobczyk C.A., CPA", "title": "Assistant Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Levant  Tinaz", "title": "Software Developer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 3, "overallRisk": 7, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.5, "open": 8.695, "dayLow": 8.16, "dayHigh": 8.695, "regularMarketPreviousClose": 8.5, "regularMarketOpen": 8.695, "regularMarketDayLow": 8.16, "regularMarketDayHigh": 8.695, "beta": 0.835, "forwardPE": -9.010988, "volume": 36823, "regularMarketVolume": 36823, "averageVolume": 35501, "averageVolume10days": 34820, "averageDailyVolume10Day": 34820, "bid": 6.01, "ask": 10.61, "bidSize": 200, "askSize": 200, "marketCap": 201394448, "fiftyTwoWeekLow": 7.11, "fiftyTwoWeekHigh": 11.69, "priceToSalesTrailing12Months": 25.55767, "fiftyDayAverage": 9.44338, "twoHundredDayAverage": 8.75021, "currency": "USD", "enterpriseValue": 180668592, "floatShares": 22183236, "sharesOutstanding": 24481800, "sharesShort": 365791, "sharesShortPriorMonth": 340605, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0145000005, "heldPercentInsiders": 0.08658, "heldPercentInstitutions": 0.44584, "shortRatio": 7.39, "bookValue": 1.603, "priceToBook": 5.1154084, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -27591000, "trailingEps": -1.22, "forwardEps": -0.91, "enterpriseToRevenue": 22.927, "enterpriseToEbitda": -6.029, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PROF", "underlyingSymbol": "PROF", "shortName": "Profound Medical Corp.", "longName": "Profound Medical Corp.", "firstTradeDateEpochUtc": 1572355800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "eb970203-d64f-3491-a67a-22dfef93037c", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.2, "targetHighPrice": 19.0, "targetLowPrice": 9.0, "targetMeanPrice": 13.79, "targetMedianPrice": 12.5, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 34079000, "totalCashPerShare": 1.392, "ebitda": -29968000, "totalDebt": 6652000, "quickRatio": 7.327, "currentRatio": 8.614, "totalRevenue": 7880000, "debtToEquity": 16.953, "revenuePerShare": 0.345, "returnOnAssets": -0.35869, "returnOnEquity": -0.66003, "freeCashflow": -14309750, "operatingCashflow": -22803000, "revenueGrowth": 0.394, "grossMargins": 0.61244, "operatingMargins": -3.50784, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]